Literature DB >> 12794306

Modulation of 4HNE-mediated signaling by proline-rich peptides from ovine colostrum.

Istvan Boldogh1, Daniel Liebenthal, T Kley Hughes, Terry L Juelich, Jerzy A Georgiades, Marian L Kruzel, G John Stanton.   

Abstract

In previous studies we showed that colostrinin (CLN), a complex of proline-rich polypeptides derived from ovine colostrum, induces mitogenic stimulation, as well as a variety of cytokines in human peripheral blood leukocytes, and possesses antioxidant activity in pheochromocytoma (PC12) cells. In this study we investigated the effects of CLN on 4-hydroxynonenal (4HNE)-mediated adduct formation, generation of reactive oxygen species (ROS), glutathione (GSH) metabolism, and the modification of signal transduction cascade that leads to activation of c-Jun N-terminal kinase (JNK) in PC12 cells. Here we demonstrate that CLN (1) reduced the abundance of 4HNE-protein adducts, as shown by fluorescent microscopy and Western blot analysis; (2) reduced intracellular levels of ROS, as shown by a decrease in 2',7'-dichlorodihydro-fluorescein-mediated fluorescence; (3) inhibited 4HNE-mediated GSH depletion, as determined fluorimetrically; and (4) inhibited 4HNE-induced activation of JNKs. Together, these findings suggest that CLN appears to down-regulate 4HNE-mediated lipid peroxidation and its product-induced signaling that otherwise may lead to pathological changes at the cellular and organ level. These findings also suggest further that CLN could be useful in the treatment of diseases such as Alzheimer's, as well as those in which ROS are implicated in pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794306     DOI: 10.1385/JMN:20:2:125

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  55 in total

Review 1.  Regulation of p53 function.

Authors:  D B Woods; K H Vousden
Journal:  Exp Cell Res       Date:  2001-03-10       Impact factor: 3.905

Review 2.  Photo-oxidation of proteins and its role in cataractogenesis.

Authors:  M J Davies; R J Truscott
Journal:  J Photochem Photobiol B       Date:  2001-10       Impact factor: 6.252

Review 3.  Cytochrome p450 and parkinsonism: protective role of CYP2E1.

Authors:  F Vaglini; C Pardini; C Viaggi; G U Corsini
Journal:  Funct Neurol       Date:  2001

4.  4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

Authors:  L M Sayre; D A Zelasko; P L Harris; G Perry; R G Salomon; M A Smith
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

5.  Regional membrane phospholipid alterations in Alzheimer's disease.

Authors:  M R Prasad; M A Lovell; M Yatin; H Dhillon; W R Markesbery
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

6.  4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis.

Authors:  S Page; C Fischer; B Baumgartner; M Haas; U Kreusel; G Loidl; M Hayn; H W Ziegler-Heitbrock; D Neumeier; K Brand
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

Review 7.  Redox regulation of cellular activation.

Authors:  H Nakamura; K Nakamura; J Yodoi
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

8.  Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction.

Authors:  J N Keller; M S Kindy; F W Holtsberg; D K St Clair; H C Yen; A Germeyer; S M Steiner; A J Bruce-Keller; J B Hutchins; M P Mattson
Journal:  J Neurosci       Date:  1998-01-15       Impact factor: 6.167

Review 9.  Mitochondrial free radical generation, oxidative stress, and aging.

Authors:  E Cadenas; K J Davies
Journal:  Free Radic Biol Med       Date:  2000-08       Impact factor: 7.376

10.  Tumor-associated antigens are cytokine inducers and hyporeactivity factors to the immune system.

Authors:  A D Inglot; F Gelder; J A Georgiades
Journal:  Biotherapy       Date:  1998
View more
  7 in total

1.  The alcohol-induced conformational changes in casein micelles: a new challenge for the purification of colostrinin.

Authors:  Marian L Kruzel; Antoni Polanowski; Tadeusz Wilusz; Agata Sokołowska; Magdalena Pacewicz; Renata Bednarz; Jerzy A Georgiades
Journal:  Protein J       Date:  2004-02       Impact factor: 2.371

2.  Colostrinin-driven neurite outgrowth requires p53 activation in PC12 cells.

Authors:  Attila Bacsi; G John Stanton; Thomas K Hughes; Marian Kruze; Istvan Boldogh
Journal:  Cell Mol Neurobiol       Date:  2005-11       Impact factor: 5.046

Review 3.  Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.

Authors:  Pradip K Kamat; Anuradha Kalani; Shivika Rai; Supriya Swarnkar; Santoshkumar Tota; Chandishwar Nath; Neetu Tyagi
Journal:  Mol Neurobiol       Date:  2014-12-17       Impact factor: 5.590

4.  Genetic Evidence for XPC-KRAS Interactions During Lung Cancer Development.

Authors:  Xiaoli Zhang; Nonggao He; Dongsheng Gu; Jeff Wickliffe; James Salazar; Istavan Boldogh; Jingwu Xie
Journal:  J Genet Genomics       Date:  2015-10-17       Impact factor: 4.275

5.  Protective Effect of Yang Mi Ryung® Extract on Noise-Induced Hearing Loss in Mice.

Authors:  Min Soo Kim; SeongAe Kwak; Heumyoung Baek; Zewu Li; Seong-Kyu Choe; Kyung Song
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-15       Impact factor: 2.629

6.  Isolation and Characterization of NP-POL Nonapeptide for Possible Therapeutic Use in Parkinson's Disease.

Authors:  Marta Lemieszewska; Antoni Polanowski; Tadeusz Wilusz; Agata Sokołowska; Aleksandra Zambrowicz; Katarzyna Mikołajewicz; Józefa Macała; Joanna Rymaszewska; Agnieszka Zabłocka
Journal:  Oxid Med Cell Longev       Date:  2018-07-18       Impact factor: 6.543

Review 7.  Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail?

Authors:  Torbjörn Persson; Bogdan O Popescu; Angel Cedazo-Minguez
Journal:  Oxid Med Cell Longev       Date:  2014-01-05       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.